Terms: = Liver cancer AND DUX4L1, DUX4, P0CJ90, P0CJ89, P0CJ88, P0CJ86, P0CJ85, 22947
3 results:
1. A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the present.
Fettiplace A; Matis-Mitchell S; Molodetskyi O; Söderbergh M; Oscarsson J; Lin M; Ravikiran S; Billger M; Ambery P
Expert Opin Drug Saf; 2024 Apr; 23(4):477-486. PubMed ID: 38469902
[TBL] [Abstract] [Full Text] [Related]
2. Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) CIC-dux4 gene fusion.
Tsukamoto Y; Futani H; Yoshiya S; Watanabe T; Kihara T; Matsuo S; Hirota S
Pathol Res Pract; 2017 Oct; 213(10):1315-1321. PubMed ID: 28645808
[TBL] [Abstract] [Full Text] [Related]
3. Primary CIC-dux4 round cell sarcoma of the kidney: A treatment-refractory tumor with poor outcome.
Bergerat S; Barthelemy P; Mouracade P; Lang H; Saussine C; Lindner V; Jacqmin D
Pathol Res Pract; 2017 Feb; 213(2):154-160. PubMed ID: 27919577
[TBL] [Abstract] [Full Text] [Related]
